HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.
about
The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza InfectionA Blueprint for HIV Vaccine DiscoveryGenetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?Revealing the role of CD4(+) T cells in viral immunityHIV therapeutic vaccines: moving towards a functional cureHost-pathogen interaction in HIV infectionA global approach to HIV-1 vaccine developmentInnate immune recognition of HIV-1Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?HIV-1 Vaccine Trials: Evolving Concepts and DesignsInduction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer ModelingImmunity to HIV in Early LifeAnalysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein.Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responsesTranscriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional featuresImmune activation and HIV persistence: implications for curative approaches to HIV infection.Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.Changes in Natural Killer cell activation and function during primary HIV-1 Infection.Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcomeHIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells.IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses.Regulation of SIV antigen-specific CD4+ T cellular immunity via autophagosome-mediated MHC II molecule-targeting antigen presentation in mice.A lower viral set point but little immunological impact after early treatment during primary HIV infectionPriming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.African green monkey TRIM5α restriction in simian immunodeficiency virus-specific rhesus macaque effector CD4 T cells enhances their survival and antiviral function.Human immunodeficiency virus vaccinesHIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection.Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost.In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.
P2860
Q26751016-D49EE242-C9CD-489F-84EE-BA69C78222FDQ26829865-11D85AE1-068F-407E-9773-365E25E36894Q26995220-DDA5CAB9-3063-4641-AE70-A983FC6EBE93Q26995409-51BAAB95-E3E0-4868-96AD-A42AC221A0F4Q27002180-8A76CDB1-4823-45A5-8AEF-CA33BC01DD75Q27009024-07A47F31-F6C3-4976-B740-CDB979FFECDDQ27024614-742781BE-BC57-4332-AB02-F66EFDFAF3F0Q27025598-1096A4C7-59D1-489D-B4D4-B2CE85E32905Q30362489-9FCD1744-F5C3-4DFF-BDEF-4771BDCD151EQ30425520-3C8349E4-7DDE-4291-A565-17D05845DC9AQ33744069-54898C70-32FC-42CE-9B22-ED0AFCD1D865Q33744109-78341032-B909-4415-AFD8-8B52334D2A82Q33780548-8191D2BB-D6BD-49DB-A5FB-75E1EBB94CC1Q34033051-B67F1092-6270-4696-B7DD-9555FE00FF93Q34057942-09A8C422-BCC6-42C6-8A6A-4867D4F25624Q34059460-D4D9C0B2-C9E9-43A6-A248-B7F4ED3484EBQ34059488-4EDF454F-EF8A-440F-9A7E-D620909CFA07Q34146397-BE981A75-0ED9-43E3-97A7-B2D2F216AFFEQ34351320-533D9B1F-2D6F-4A20-A729-E57AACFDE917Q34480617-1DA3B9C2-4ED2-4B8C-9DCE-A332178F7CBDQ34510458-B8175F4E-3BD3-4ADF-9416-05AEC089B53CQ34551274-8F3BF24B-EE94-4069-8ADC-70A617F4D919Q34593765-B86D4515-5BF0-4451-A059-A046F01C67E3Q34594538-592183F8-FF44-4A69-8EB9-C2C018CE4992Q34594890-878FC762-60FF-4AC1-B2B2-421456A4FE8DQ34677320-2A173E48-B9D8-4B09-B314-0FCAF0FF6378Q35106552-CFB88416-0532-49BF-A59A-F04349F80184Q35106912-36D844EC-49AA-453A-BB48-2137F98ADA15Q35132375-37DAD165-DB0C-458C-B1F6-FDDEC268A5A4Q35323147-32323867-8DA1-4F10-A157-742E28DA020FQ35431516-B72875D8-2F5C-400A-AFF9-11EF3C7E1E6CQ35487807-FBD27A24-BE6A-483D-BAD8-888F890299DAQ35641022-BAE802C1-18C6-4692-9873-658640B262A6Q35674731-E3EF609D-F6C5-42B8-8F1E-B9B7FD2E0126Q35677513-D2759C1C-8411-4934-986D-C44E3D705FE1Q35753766-94E079FA-EA11-45B3-86DE-68A08546EA79Q35806053-42559294-E33C-4289-8D3E-F160D0202AC0Q35861240-9920FD58-01C3-418B-A46E-A7901D76DB44Q35883997-F231AE42-989D-459B-AF11-4E74556B2ACAQ35887235-D29EA7F7-0506-4753-8ABC-BCE4A9C896EC
P2860
HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV-specific cytolytic CD4 T c ...... ction predict disease outcome.
@en
type
label
HIV-specific cytolytic CD4 T c ...... ction predict disease outcome.
@en
prefLabel
HIV-specific cytolytic CD4 T c ...... ction predict disease outcome.
@en
P2093
P2860
P50
P1476
HIV-specific cytolytic CD4 T c ...... ction predict disease outcome.
@en
P2093
Abraham L Brass
Damien Z Soghoian
Heiko Jessen
Isaiah Davis
Jason M Brenchley
Jenna Rychert
Kailan Sierra-Davidson
Kimberly Lane
Madelene Lindqvist
Michael Flanders
P2860
P304
P356
10.1126/SCITRANSLMED.3003165
P407
P577
2012-02-01T00:00:00Z